sia9532 יצר מאמר חדש
16 ב - תרגם

Liver Fibrosis IL Inhibitors Market Expands on Back of Advancements in Anti-Fibrotic Therapies | #il inhibitors # liver fibrosis treatment # interleukin therapy # chronic liver disease drugs # anti-fibrotic agents

Liver Fibrosis IL Inhibitors Market Expands on Back of Advancements in Anti-Fibrotic Therapies

Liver Fibrosis IL Inhibitors Market Expands on Back of Advancements in Anti-Fibrotic Therapies

The global liver fibrosis interleukin (Il) inhibitors market was valued at USD 776.62 million in 2024 and is expected to reach USD 1738.80 million by 2032